Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- The ex-dividend date for Teva Pharmaceutical Industries (NYSE: TEVA) is tomorrow, May 16, 2013. Owners of shares as of market close today will be eligible for a dividend of 27 cents per share. At a price of $39.71 as of 9:31 a.m. ET, the dividend yield is 2.4%. The average volume for Teva has been 4.1 million shares per day over the past 30 days. Teva has a market cap of $33.43 billion and is part of the health care sector and drugs industry. Shares are up 6.6% year to date as of the close of trading on Tuesday. Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. The company has a P/E ratio of 17.4, below the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Teva as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. You can view the full Teva Ratings Report. See our dividend calendar or top-yielding stocks list. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.